About Cognate Bioservices
Cognate Bioservices is a company based in Hanover (United States) founded in 2002 was acquired by Charles River Laboratories in February 2021.. The company has 302 employees as of December 31, 2021. Cognate Bioservices has completed 1 acquisition, including Cobra Biologics. Cognate Bioservices offers products and services including Plasmid DNA Manufacturing, Viral Vector Manufacturing, Cell Therapy Manufacturing, Viral Vector Packaging, and Custom Cloning. Cognate Bioservices operates in a competitive market with competitors including Orgenesis, Ori Biotech, MaSTherCell, SpliSense and eXmoor, among others.
- Headquarter Hanover, United States
- Employees 302 as on 31 Dec, 2021
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cognate Bioservices Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
-
Investors
Charles River Laboratories
& 3 more
-
Employee Count
302
as on Dec 31, 2021
- Investments & Acquisitions
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cognate Bioservices
Cognate Bioservices offers a comprehensive portfolio of products and services, including Plasmid DNA Manufacturing, Viral Vector Manufacturing, Cell Therapy Manufacturing, Viral Vector Packaging, and Custom Cloning. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Produces plasmid DNA for cell and gene therapy applications.
Develops viral vectors for gene therapy and related therapies.
Handles manufacturing of cell therapies for clinical use.
Packages viral vectors for safe therapy delivery.
Offers custom cloning for gene therapy research.
Unlock access to complete
Software Development Team
73 people
Leadership Team
64 people
Sales and Marketing
56 people
Human Resources and Administration
42 people
Senior Team
23 people
Product Management Team
22 people
Operations Team
21 people
Data Analysis and Operations Team
12 people
Unlock access to complete
Funding Insights of Cognate Bioservices
- Total Funding Total Funding
- Total Rounds 3
- Last Round Last Round
- First Round First Round
- Investors Count 3
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2020 | Amount | Series B - Cognate Bioservices | Valuation | EW Healthcare Partners | |
| Aug, 2019 | Amount | Series B - Cognate Bioservices | Valuation | EW Healthcare Partners | |
| Feb, 2018 | Amount | Series A - Cognate Bioservices | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cognate Bioservices
Cognate Bioservices has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include Charles River Laboratories, Tennenbaum Capital Partners and EW Healthcare Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Growth-stage healthcare companies are invested in by EW Healthcare Partners.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
A diversified portfolio of investment management services is offered.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cognate Bioservices
Cognate Bioservices has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Cobra Biologics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Biologics development and manufacturing services are provided contractually.
|
1992 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Cognate Bioservices
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cognate Bioservices Comparisons
Competitors of Cognate Bioservices
Cognate Bioservices operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Orgenesis, Ori Biotech, MaSTherCell, SpliSense and eXmoor, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Cell and gene therapies for multiple disorders are developed.
|
|
| domain | founded_year | HQ Location |
Software development services are provided for the biopharma sector.
|
|
| domain | founded_year | HQ Location |
Services for cell therapy development and manufacturing are provided.
|
|
| domain | founded_year | HQ Location |
Limited information available
|
|
| domain | founded_year | HQ Location |
Cell and gene therapeutic services are provided to biopharmaceutical firms.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cognate Bioservices
Frequently Asked Questions about Cognate Bioservices
When was Cognate Bioservices founded?
Cognate Bioservices was founded in 2002 and raised its 1st funding round 16 years after it was founded.
Where is Cognate Bioservices located?
Cognate Bioservices is headquartered in Hanover, United States. It is registered at Hanover, New Hampshire, United States.
How many employees does Cognate Bioservices have?
As of Dec 31, 2021, the latest employee count at Cognate Bioservices is 302.
What does Cognate Bioservices do?
Founded in 2002 and based in Hanover, United States, Cognate Bioservices operates in the regenerative medicine sector. Full development and cGMP manufacturing services are offered to support cell-based products from preclinical studies through commercial production. Capabilities encompass autologous and allogeneic technologies, including stem cells, immune cells, and other differentiated types. A FDA-inspected facility is maintained for cell isolation and expansion, with regulatory support also provided.
Who are the top competitors of Cognate Bioservices?
Cognate Bioservices's top competitors include Ori Biotech, MaSTherCell and OBiO Technology.
What products or services does Cognate Bioservices offer?
Cognate Bioservices offers Plasmid DNA Manufacturing, Viral Vector Manufacturing, Cell Therapy Manufacturing, Viral Vector Packaging, and Custom Cloning.
How many acquisitions has Cognate Bioservices made?
Cognate Bioservices has made 1 acquisition, including Cobra Biologics.
Who are Cognate Bioservices's investors?
Cognate Bioservices has 4 investors. Key investors include Charles River Laboratories, Tennenbaum Capital Partners, EW Healthcare Partners, and Medivate Partners.